Advertisement
Screener

GAIN THERAPEUTICS, INC (GANX) Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three

GAIN THERAPEUTICS, INC Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three

GAIN THERAPEUTICS, INC (GANX) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three of $47.91 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree · last filed 2026-08-11

  • 2026-06-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three $47.91K.
  • 2026-03-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three $48.59K.
  • 2025-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three $49.28K.
  • 2025-09-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three $33.45K.
Period endLessee, Operating Lease, Liability, Payments, Due in Rolling Year Three
2026-06-30$47.91K
10-Q · filed 2026-08-11
2026-03-31$48.59K
10-Q · filed 2026-05-11
2025-12-31$49.28K
10-K · filed 2026-03-26
2025-09-30$33.45K
10-Q · filed 2025-11-12
2025-06-30$33.60K
10-Q · filed 2025-08-12
2024-09-30$4.82K
10-Q · filed 2024-11-14
2024-06-30$11.60K
10-Q · filed 2024-08-08
2024-03-31$30.48K
10-Q · filed 2024-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B